HF is not only detrimental to the patient but also impacts funding, reimbursement methods, economy, businesses and cost of our society. The rate of HF readmissions will continue to increase with time due to the aging population. Implementing strategies to offset these causes are important for the financial growth of healthcare today. Elimination of all probable causes prior to discharge will result in evidence based outcomes and promote a longer lifespan. Although, due to the recent presidential election, it is currently uncertain how HF readmissions may affect our future economic standpoint. Therefore, the healthcare environment must continue to review processes to be incoherent with possible upcoming changes.